Workshop Day

Tuesday, August 29

Morning Workshops


Workshop A: Extending the Reach of CAR-T Cell Therapies Beyond Oncology to Autoimmune Diseases

Greg Deener, Chief Executive Officer, iCell Gene Therapeutics

Samik Basu, Chief Scientific Officer, Cabaletta Bio


Workshop B: Leveraging Combination Strategies to Optimize the Efficacy of Cell Therapies

Daniel Corey, Founder & Chief Executive Officer, CERo Therapeutics

Francesca Barone, Chief Scientific Officer, Candel Therapeutics

Steven Katz, Chief Medical, TriSalus Life Science


Workshop C: Implementing Technological Innovations to Enable Automated Cell Therapy Manufacturing

Bruce Levine, Barbara & Edward Netter Professor in Cancer Gene Therapy & Center for Cellular Immunotherapies Director of Technology Innovation, University of Pennsylvania

Krishnendu Roy, Director NSF ERC for Cell Manufacturing Technologies & Marcus Center for Therapeutic Cell Characterization & Manufacturing, Georgia Institute of Technology

Afternoon Workshops


Workshop D: Moving Beyond Ex Vivo: The Promise of In Vivo Engineered Cell Therapies

Jim Edinger, Vice President, Preclinical Science, Mustang Bio

Kutlu Elpek, Senior Director, T Cell Therapeutics, Research Lead, In Vivo CAR-T, Sana Biotechnology

Michael Rosenzweig, Executive Vice President, Strategy & Product Development, Capstan Therapeutics


Workshop E: Outlining Key Regulatory Considerations for IND & BLA Approval of Novel Cell Therapies

Alison Holzer-Speed, Senior Director, Regulatory Affairs, Early Development, Kite, A Gilead Company

Brian Kevany, Chief Technology Officer & Head of Research, Abeona Therapeutics

Omer Butt, Vice President, Regulatory Affairs, CytoImmune Therapeutics


Workshop F: A CAR-T Cell Manufacturing Life-Cycle Approach for Dramatic Reduction in Cost and Time Towards Making Cell Therapies More Affordable Globally

Bikash Verma, Chief Executive Officer, MedTherapy Biotech

Vladimir Slepushkin, Chief Technology Officer, MedTherapy Biotech

“Learned a lot, glad I attended. Workshop format was great for learning and networking.”
Lilit Minasian, Regulatory Affairs Director, Poseida Therapeutics, Past Attendee